We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




DCL Medical Laboratories Sold to Laboratory Corporation of America

By LabMedica International staff writers
Posted on 28 Jul 2010
Thompson Street Capital Partners (St. More...
Louis, MO, USA) have sold DCL Medical Laboratories, LLC (DCL) to Laboratory Corporation of America Holdings (LabCorp; Burlington, NC, USA), a U.S. provider of medical laboratory tests and services. Terms of the transaction were not disclosed.

DCL provides diagnostic and clinical trial testing services to physicians, hospitals, and pharmaceutical and medical device companies. The company provides anatomic pathology as well as clinical trial testing services and specializes in women's health.

LabCorp offers clinical assays ranging from routine blood analysis to HIV and genomic testing. DCL will join LabCorp's nationwide network of 38 primary testing locations and its industry-leading Centers of Excellence laboratories, including the Center for Esoteric Testing, Viro-Med, National Genetics Institute and US Labs.

In 2007, Thompson Street, together with Jack Bergstrom and Jay Tyler, acquired DCL from its founders. The goal of the transaction was to capitalize and expand the company's strong reputation in women's health. Thompson Street's managing partner, Jim Cooper, said, "We achieved this by growing our sales force and laboratory staff, increasing our participation in pharmaceutical and medical device clinical trials, and investing in our laboratory IT and test equipment infrastructure."

Related Links:
Thompson Street Capital Partners
Laboratory Corporation of America Holdings


New
Gold Member
Automatic CLIA Analyzer
Shine i9000
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The new analysis of blood samples links specific protein patterns to five- and ten-year mortality risk (Photo courtesy of Adobe Stock)

Blood Protein Profiles Predict Mortality Risk for Earlier Medical Intervention

Elevated levels of specific proteins in the blood can signal increased risk of mortality, according to new evidence showing that five proteins involved in cancer, inflammation, and cell regulation strongly... Read more

Hematology

view channel
Image: Research has linked platelet aggregation in midlife blood samples to early brain markers of Alzheimer’s (Photo courtesy of Shutterstock)

Platelet Activity Blood Test in Middle Age Could Identify Early Alzheimer’s Risk

Early detection of Alzheimer’s disease remains one of the biggest unmet needs in neurology, particularly because the biological changes underlying the disorder begin decades before memory symptoms appear.... Read more

Microbiology

view channel
Image: The SMART-ID Assay delivers broad pathogen detection without the need for culture (Photo courtesy of Scanogen)

Rapid Assay Identifies Bloodstream Infection Pathogens Directly from Patient Samples

Bloodstream infections in sepsis progress quickly and demand rapid, precise diagnosis. Current blood-culture methods often take one to five days to identify the pathogen, leaving clinicians to treat blindly... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.